扶桑薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/25 | 2,025 | 2,026 | 2,015 | 2,021 | +1 | ±0% | 41,200 |
2023/09/22 | 2,013 | 2,025 | 2,005 | 2,020 | -7 | -0.3% | 64,000 |
2023/09/21 | 2,031 | 2,033 | 2,012 | 2,027 | -8 | -0.4% | 113,800 |
2023/09/20 | 2,061 | 2,068 | 2,031 | 2,035 | -6 | -0.3% | 394,500 |
2023/09/19 | 2,039 | 2,045 | 2,030 | 2,041 | +2 | +0.1% | 114,500 |
2023/09/15 | 2,033 | 2,057 | 2,033 | 2,039 | +3 | +0.1% | 67,900 |
2023/09/14 | 2,052 | 2,069 | 2,031 | 2,036 | -12 | -0.6% | 74,700 |
2023/09/13 | 2,016 | 2,062 | 2,007 | 2,048 | -154 | -7% | 208,100 |
2023/09/12 | 2,182 | 2,202 | 2,177 | 2,202 | +23 | +1.1% | 9,700 |
2023/09/11 | 2,146 | 2,200 | 2,131 | 2,179 | +56 | +2.6% | 10,400 |
2023/09/08 | 2,154 | 2,193 | 2,123 | 2,123 | -40 | -1.8% | 16,100 |
2023/09/07 | 2,182 | 2,218 | 2,162 | 2,163 | -47 | -2.1% | 17,600 |
2023/09/06 | 2,214 | 2,219 | 2,165 | 2,210 | +96 | +4.5% | 31,800 |
2023/09/05 | 2,108 | 2,114 | 2,093 | 2,114 | +6 | +0.3% | 6,000 |
2023/09/04 | 2,079 | 2,108 | 2,073 | 2,108 | +40 | +1.9% | 7,800 |
2023/09/01 | 2,078 | 2,078 | 2,059 | 2,068 | -10 | -0.5% | 6,500 |
2023/08/31 | 2,074 | 2,084 | 2,072 | 2,078 | -6 | -0.3% | 5,300 |
2023/08/30 | 2,089 | 2,096 | 2,084 | 2,084 | -13 | -0.6% | 7,900 |
2023/08/29 | 2,075 | 2,097 | 2,075 | 2,097 | -6 | -0.3% | 3,700 |
2023/08/28 | 2,098 | 2,103 | 2,080 | 2,103 | +8 | +0.4% | 5,600 |
2023/08/25 | 2,105 | 2,105 | 2,089 | 2,095 | -10 | -0.5% | 4,300 |
2023/08/24 | 2,071 | 2,112 | 2,062 | 2,105 | +38 | +1.8% | 15,600 |
2023/08/23 | 2,027 | 2,070 | 2,027 | 2,067 | +28 | +1.4% | 4,500 |
2023/08/22 | 2,044 | 2,052 | 2,034 | 2,039 | +11 | +0.5% | 6,200 |
2023/08/21 | 2,012 | 2,036 | 2,012 | 2,028 | +10 | +0.5% | 7,600 |
2023/08/18 | 2,011 | 2,018 | 2,000 | 2,018 | +10 | +0.5% | 7,800 |
2023/08/17 | 2,037 | 2,037 | 2,007 | 2,008 | -29 | -1.4% | 6,400 |
2023/08/16 | 2,020 | 2,056 | 2,020 | 2,037 | +1 | ±0% | 4,300 |
2023/08/15 | 2,016 | 2,060 | 2,015 | 2,036 | +16 | +0.8% | 5,000 |
2023/08/14 | 2,053 | 2,058 | 2,004 | 2,020 | -34 | -1.7% | 6,200 |
2023/08/10 | 2,042 | 2,054 | 2,018 | 2,054 | +13 | +0.6% | 4,800 |
2023/08/09 | 2,034 | 2,054 | 2,030 | 2,041 | -16 | -0.8% | 9,700 |
2023/08/08 | 2,046 | 2,065 | 2,046 | 2,057 | +7 | +0.3% | 3,300 |
2023/08/07 | 2,030 | 2,050 | 2,012 | 2,050 | +32 | +1.6% | 6,000 |
2023/08/04 | 2,013 | 2,034 | 2,012 | 2,018 | +5 | +0.2% | 3,500 |
2023/08/03 | 2,041 | 2,050 | 2,003 | 2,013 | -43 | -2.1% | 9,000 |
2023/08/02 | 2,070 | 2,074 | 2,050 | 2,056 | -14 | -0.7% | 5,300 |
2023/08/01 | 2,062 | 2,074 | 2,052 | 2,070 | +8 | +0.4% | 7,500 |
2023/07/31 | 2,073 | 2,077 | 2,053 | 2,062 | +39 | +1.9% | 12,100 |
2023/07/28 | 2,067 | 2,067 | 2,023 | 2,023 | -33 | -1.6% | 16,100 |
2023/07/27 | 2,058 | 2,072 | 2,056 | 2,056 | -5 | -0.2% | 5,700 |
2023/07/26 | 2,050 | 2,092 | 2,050 | 2,061 | +11 | +0.5% | 15,100 |
2023/07/25 | 2,065 | 2,069 | 2,050 | 2,050 | -4 | -0.2% | 4,700 |
2023/07/24 | 2,045 | 2,062 | 2,042 | 2,054 | +12 | +0.6% | 7,600 |
2023/07/21 | 2,022 | 2,048 | 2,022 | 2,042 | +20 | +1% | 4,600 |
2023/07/20 | 2,053 | 2,053 | 2,009 | 2,022 | -26 | -1.3% | 22,400 |
2023/07/19 | 2,016 | 2,048 | 2,016 | 2,048 | +44 | +2.2% | 17,900 |
2023/07/18 | 1,997 | 2,021 | 1,997 | 2,004 | +13 | +0.7% | 7,700 |
2023/07/14 | 1,993 | 2,010 | 1,987 | 1,991 | -1 | -0.1% | 6,900 |
2023/07/13 | 2,010 | 2,010 | 1,987 | 1,992 | +1 | +0.1% | 7,200 |
151~
200
件表示中 / 3451件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
扶桑薬 | 224,600円 | +4.5% | -9.7% | 3.12% | 14.77倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
サンバイオ | 42,700円 | - | - | 0.00% | - | 11.34倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
クオリプス | 347,500円 | -15.8% | - | 0.00% | - | 4.48倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
大幸薬品 | 35,000円 | +11.1% | - | 0.00% | 31.94倍 | 2.60倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
オンコリス | 68,300円 | +217.5% | - | 0.00% | - | 9.77倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
市場注目の銘柄
チャート関連のコラム